Differences in the Seroprevalence of SARS-CoV-2 in Children from Confirmed Covid-19 Healthworkers with or without Symptoms in RSUP Dr.Mohammad Hoesin Palembang
DOI:
https://doi.org/10.55324/josr.v5i1.2919Keywords:
COVID-19, seroprevalence, IgG SARS-CoV-2Abstract
The surge of COVID-19 cases in June 2021 underscored the role of healthcare workers (HCWs) as potential sources of household transmission, including to their children. This study aimed to analyze the differences in SARS-CoV-2 seroprevalence among children of HCWs at RSUP Dr Mohammad Hoesin Hospital, Palembang, based on parental symptom status, and to identify influencing factors. A cross-sectional study was conducted involving 61 children of HCWs confirmed with COVID-19. SARS-CoV-2 IgG levels were measured using the Chemiluminescence Microparticle Immunoassay (CMIA). Statistical analyses included Chi-square/Fisher’s exact tests and logistic regression. Results showed that 86.8% of subjects had reactive IgG, with 54.1% being children of symptomatic HCWs. The mean age was 6.9 (±3.18) years, with a male-to-female ratio of 1.3:1. While seroprevalence did not differ significantly between groups (p=0.079), IgG levels were significantly higher in children of symptomatic HCWs (median 3112 AU/ml vs. 758.9 AU/ml, p=0.02). Symptomatic children also had higher median IgG levels (3270 AU/ml vs. 1324 AU/ml). A strong negative correlation was found between parental CT-value and child’s IgG level (r = -0.64, p=0.001). Multivariate analysis identified CT-value as the sole significant risk factor for seroprevalence (p=0.003, AUC=100%). In conclusion, although seroprevalence did not differ, IgG levels were significantly higher in children of symptomatic HCWs, with parental viral load (CT-value) being the key determinant of seropositivity.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Enggrajati Silitonga, Yulia Iriani, Ariesti Kamila, Moretta Damayanti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
